Camelot Portfolios’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$514K Buy
1,835
+563
+44% +$148K 0.36% 110
2026
Q1
$339K Sell
1,272
-54
-4% -$14.6K 0.25% 135
2025
Q4
$333K Sell
1,326
-87
-6% -$23.1K 0.2% 134
2025
Q3
$406K Sell
1,413
-874
-38% -$234K 0.24% 118
2025
Q2
$600K Sell
2,287
-40
-2% -$9.74K 0.36% 92
2025
Q1
$542K Buy
+2,327
New +$565K 0.33% 105
2024
Q3
Sell
-2,833
Closed -$577K 367
2024
Q2
$577K Buy
+2,833
New +$576K 0.33% 87
2024
Q1
Sell
-2,697
Closed -$613K 174
2023
Q4
$613K Buy
+2,697
New +$567K 0.36% 85
2023
Q3
Sell
-3,343
Closed -$693K 168
2023
Q2
$693K Buy
3,343
+495
+17% +$96K 0.43% 70
2023
Q1
$561K Buy
2,848
+15
+0.5% +$3.09K 0.39% 79
2022
Q4
$573K Buy
+2,833
New +$554K 0.42% 72
2022
Q3
Sell
-2,756
Closed -$555K 188
2022
Q2
$555K Buy
2,756
+26
+1% +$5.54K 0.33% 99
2022
Q1
$618K Sell
2,730
-1,391
-34% -$327K 0.31% 101
2021
Q4
$1.11M Buy
4,121
+1,034
+33% +$256K 0.45% 65
2021
Q3
$746K Sell
3,087
-1,635
-35% -$412K 0.38% 78
2021
Q2
$1.12M Sell
4,722
-338
-7% -$77K 0.45% 63
2021
Q1
$1.11M Buy
5,060
+1,805
+55% +$362K 0.46% 67
2020
Q4
$569K Buy
3,255
+596
+22% +$103K 0.3% 89
2020
Q3
$430K Buy
2,659
+460
+21% +$72.9K 0.27% 94
2020
Q2
$314K Sell
2,199
-1,118
-34% -$155K 0.2% 132
2020
Q1
$360K Buy
3,317
+697
+27% +$100K 0.2% 131
2019
Q4
$381K Buy
2,620
+252
+11% +$36.4K 0.16% 145
2019
Q3
$342K Buy
2,368
+284
+14% +$41.4K 0.16% 145
2019
Q2
$309K Hold
2,084
0.13% 175
2019
Q1
$274K Hold
2,084
0.11% 195
2018
Q4
$226K Buy
2,084
+355
+21% +$47.6K 0.11% 193
2018
Q3
$258K Buy
1,729
+175
+11% +$26.6K 0.12% 175
2018
Q2
$240K Buy
+1,554
New +$235K 0.1% 180

Other funds holding LH

Camelot Portfolios's LH Position: Q2 2026 in Review

Camelot Portfolios increased its Labcorp (LH) stake by 44% in Q2 2026, buying an estimated $148K and bringing the position to 1,835 shares worth $514K. The position accounts for 0.36% of the portfolio, ranked #110.

Camelot Portfolios first reported a position in LH in Q2 2018 and has held it in 28 quarters since. The position peaked at $1.12M in Q2 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Camelot Portfolios held 1,835 shares of Labcorp worth $514K as of Q2 2026.
  • Camelot Portfolios bought 563 Labcorp shares in Q2 2026, an estimated $148K.
  • Labcorp made up 0.36% of Camelot Portfolios's portfolio in Q2 2026, its #110 holding.
  • Camelot Portfolios first reported a position in Labcorp in Q2 2018 and has held it in 28 quarters since.
  • Camelot Portfolios's Labcorp position peaked at $1.12M in Q2 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.